sEH inhibition elevates EET levels, which would be expected to elicit a variety of beneficial biological effects [17] that effectively treat atherosclerosis, diabetes, hypertension, lung disease, pain, inflammation, immune disorders, and other diseases [18]. This evidence concerns the gene EPHX2 and lung disorder.